Your Article Summary
See Latest ArticlesGlucocerebroside: an evolutionary advantage for patients with Gaucher disease and a new immunomodulatory agent
Immunology & Cell Biology, 06/17/09
Ilan Y et al. - Clinical trials suggested a beneficial effect of GC in type 2 diabetes or nonalcoholic steatohepatitis. Indirectly, these data support treating symptomatic patients with mild/moderate GD with low-dose ERT and re-evaluating the use of ERT in asymptomatic patients.
Today in Endocrine...keeping you current
Receive free subspecialty "5-minute updates" via email
The Differences in Blood Levels of Lipids, Adipokines, and Proinflammatory Cytokines Among Normal, Overweight, and Obese Korean Women
The Endocrinologist, 11/16/09
Obesity and low-grade inflammation: a paediatric perspective
Obesity Reviews, 11/02/09
Clinical Applications of Diabetes Antibody Testing
Journal of Clinical Endocrinology and Metabolism, 11/02/09